Lægemidlets farmakokinetik var ens hos patienter med let nedsat nyrefunktion (kreatinin clearance større end 40 ml/ min) og hos raske frivillige.
The pharmacokinetics of the drug were similar in patients with mild impairment (creatinine clearance higher than 40 ml/ min) and healthy volunteers.